Patents by Inventor Wolfram Eisenreich

Wolfram Eisenreich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF
    Publication number: 20240148656
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a SGLT-2 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: January 16, 2024
    Publication date: May 9, 2024
    Inventors: Peter SCHNEIDER, Wolfram EISENREICH, Nantharat PEARNCHOB-HOEHLING
  • PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF
    Publication number: 20220331326
    Abstract: The present invention relates to pharmaceutical compositions of linagliptin, pharmaceutical dosage forms, their preparation, their use and methods for treating metabolic disorders.
    Type: Application
    Filed: November 19, 2021
    Publication date: October 20, 2022
    Inventor: Wolfram EISENREICH
  • PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF
    Publication number: 20220193045
    Abstract: The present invention relates to pharmaceutical compositions comprising a SGLT-2 inhibitor, pharmaceutical dosage forms, their preparation, their use and methods for treating metabolic disorders.
    Type: Application
    Filed: March 4, 2022
    Publication date: June 23, 2022
    Inventors: Wolfram EISENREICH, Nadia S. LADYZHYNSKY, Danping LI, Leon SCHULTZ, Zeren WANG, Sreeraj MACHA, Albert BARTA
  • PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF
    Publication number: 20200188306
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a SGLT-2 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: February 21, 2020
    Publication date: June 18, 2020
    Inventors: Peter SCHNEIDER, Wolfram EISENREICH, Nantharat PEARNCHOB-HOEHLING
  • Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
    Patent number: 10610489
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a SGLT-2 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Grant
    Filed: September 30, 2010
    Date of Patent: April 7, 2020
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Peter Schneider, Wolfram Eisenreich, Nantharat Pearnchob
  • PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF
    Publication number: 20180289678
    Abstract: The present invention relates to pharmaceutical compositions comprising a SGLT-2 inhibitor, pharmaceutical dosage forms, their preparation, their use and methods for treating metabolic disorders.
    Type: Application
    Filed: June 11, 2018
    Publication date: October 11, 2018
    Inventors: Wolfram EISENREICH, Nadia S. LADYZHYNSKY, Danping LI, Leon SCHULTZ, Zeren WANG, Sreeraj MACHA, Albert BARTA
  • PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF
    Publication number: 20180104249
    Abstract: The present invention relates to pharmaceutical compositions of linagliptin, pharmaceutical dosage forms, their preparation, their use and methods for treating metabolic disorders.
    Type: Application
    Filed: December 19, 2017
    Publication date: April 19, 2018
    Inventor: Wolfram EISENREICH
  • Pharmaceutical Compositions for the Treatment of Sexual Disorders II
    Publication number: 20150320739
    Abstract: The invention relates to new pharmaceutical compositions for the treatment of sexual disorders and methods for the preparation thereof. In a preferred embodiment, the instant invention is directed to pharmaceutical combinations comprising flibanserin as one active ingredient in combination with at least one additional active ingredient for the treatment of sexual disorders and methods for the preparation thereof.
    Type: Application
    Filed: March 13, 2015
    Publication date: November 12, 2015
    Inventors: Klaus Mendla, Thomas Friedl, Wolfram Eisenreich, Robert E. Pyke
  • Extended Release Tablet Formulation Containing Pramipexole or a Pharmaceutically Acceptable Salt Thereof
    Publication number: 20140335175
    Abstract: An extended release tablet formulation comprising pramipexole or a pharmaceutically acceptable salt thereof in a matrix comprising at least one water swelling polymer other than pregelatinized starch.
    Type: Application
    Filed: July 24, 2014
    Publication date: November 13, 2014
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Thomas FRIEDL, Wolfram EISENREICH
  • Extended release tablet formulations of flibanserin and method for manufacturing the same
    Patent number: 8658207
    Abstract: The present invention provides pharmaceutical release systems comprising an therapeutically effective amount of flibanserin and at least one pharmaceutically acceptable excipient, characterized in that said pharmaceutical release systems exhibit a pharmacokinetic profile that is characterized by an average maximum flibanserin plasma concentration Cmax lower than 300 ng/mL, preferably lower than 200 ng/mL after administration of a single dose to healthy volunteers in fasted state or directly after a meal.
    Type: Grant
    Filed: August 13, 2007
    Date of Patent: February 25, 2014
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Wolfram Eisenreich, Thomas Friedl, Florian Sommer, Nantharat Pearnchob, Karl G. Wagner
  • Extended release tablet formulations of flibanserin and method for manufacturing the same
    Patent number: 8545886
    Abstract: The invention is directed to a Pharmaceutical extended release system, particularly for oral administration, of a pH-dependent water-soluble active substance, comprising or essentially consisting of a) flibanserin or a pharmaceutically acceptable derivative thereof as active substance; b) one or more pharmaceutically acceptable pH-dependent polymers; c) one or more pharmaceutically acceptable pH-independent polymers; d) one or more pharmaceutically acceptable acids; and e) optionally one or more additives. The present invention provides a release profile of flibanserin which is independent on the pH in the gastrointestinal tract when administered orally resulting in a significantly improved bioavailability.
    Type: Grant
    Filed: August 13, 2007
    Date of Patent: October 1, 2013
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Wolfram Eisenreich, Thomas Friedl
  • Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
    Patent number: 8377977
    Abstract: An extended release tablet formulation comprising pramipexole or a pharmaceutically acceptable salt thereof in a matrix comprising at least one water swelling polymer other than pregelatinized starch.
    Type: Grant
    Filed: July 22, 2009
    Date of Patent: February 19, 2013
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Thomas Friedl, Wolfram Eisenreich
  • Extended Release Formulation
    Publication number: 20120282338
    Abstract: The invention is directed to an extended release formulation comprising pramipexole or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 19, 2012
    Publication date: November 8, 2012
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Thomas FRIEDL, Wolfram EISENREICH, Sebastian HAERTTER
  • Modified Release Formulation
    Publication number: 20120282337
    Abstract: The invention is directed to the use of an extended release tablet formulation for pramipexole.
    Type: Application
    Filed: July 12, 2012
    Publication date: November 8, 2012
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Thomas FRIEDL, Wolfram EISENREICH
  • PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF
    Publication number: 20110236477
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a SGLT-2 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: September 30, 2010
    Publication date: September 29, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Peter Schneider, Wolfram Eisenreich, Nantharat Pearnchob
  • Extended Release Formulation
    Publication number: 20110195122
    Abstract: The invention is directed to an extended release formulation comprising pramipexole or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 14, 2011
    Publication date: August 11, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Thomas FRIEDL, Wolfram EISENREICH, Sebastian HAERTTER
  • Modified Release Formulation
    Publication number: 20110150994
    Abstract: The invention is directed to the use of an extended release tablet formulation for pramipexole.
    Type: Application
    Filed: February 28, 2011
    Publication date: June 23, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Thomas FRIEDL, Wolfram EISENREICH
  • Pharmaceutical Compositions for the Treatment of Sexual Disorders II
    Publication number: 20110105519
    Abstract: The invention relates to new pharmaceutical compositions for the treatment of sexual disorders and methods for the preparation thereof. In a preferred embodiment, the instant invention is directed to pharmaceutical combinations comprising flibanserin as one active ingredient in combination with at least one additional active ingredient for the treatment of sexual disorders and methods for the preparation thereof.
    Type: Application
    Filed: January 10, 2011
    Publication date: May 5, 2011
    Inventors: Klaus Mendla, Thomas Friedl, Wolfram Eisenreich, Robert Pyke
  • PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF
    Publication number: 20110014284
    Abstract: The present invention relates to pharmaceutical compositions comprising a SGLT-2 inhibitor, pharmaceutical dosage forms, their preparation, their use and methods for treating metabolic disorders.
    Type: Application
    Filed: February 11, 2010
    Publication date: January 20, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Wolfram EISENREICH, Nadia S. LADYZHYNSKY, Danping LI, Leon SCHULTZ, Zeren WANG, Sreeraj MACHA, Albert BARTA
  • PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF
    Publication number: 20100209506
    Abstract: The present invention relates to pharmaceutical compositions of linagliptin, pharmaceutical dosage forms, their preparation, their use and methods for treating metabolic disorders.
    Type: Application
    Filed: February 11, 2010
    Publication date: August 19, 2010
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventor: Wolfram EISENREICH